Direxion Daily S&P Biotech Bear 3X Shares LABD
Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
Ticker | Name | Share Class Type | Investment Status | Morningstar Rating for Funds Overall | Medalist Rating Overall | Inception Date | Total Net Assets for Share Class | Adjusted Expense Ratio | Fee Level Distribution | Minimum Initial Investment | 1-Year Net Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|
LABD | Direxion Daily S&P Biotech Bear 3X Shares | ETF | Open | — | — | $77.85M | 1.070% | — | — | $90.35M | |
LABD | Direxion Daily S&P Biotech Bear 3X Shares | ETF | Open | — | — | — | 1.070% | — | — | — |